Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes

View More View Less
  • 1 Departments of Neurology and Neurosurgery,
  • 2 Hematology, and
  • 4 Emergency Medicine, McGill University Health Centre, Montreal, Quebec; and
  • 3 Department of Psychology, University of Montreal, Quebec, Canada
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

OBJECTIVE

Among the elderly, use of antithrombotics (ATs), antiplatelets (APs; aspirin, clopidogrel), and/or anticoagulants (ACs; warfarin, direct oral ACs [DOACs; dabigatran, rivaroxaban, apixaban]) to prevent thromboembolic events must be carefully weighed against the risk of intracranial hemorrhage (ICH) with trauma. The goal of this study was to assess the risk of sustaining a traumatic brain injury (TBI), ICH, and poorer outcomes in relation to AT use among all patients 65 years or older presenting to a single institution with head trauma.

METHODS

Data were collected from all head trauma patients 65 years or older presenting to the authors’ supraregional tertiary trauma center over a 24-month period and included age, sex, injury mechanism, medical history, international normalized ratio, Glasgow Coma Scale (GCS) score, ICH presence and type, hospital admission, reversal therapy, surgery, discharge destination, Extended Glasgow Outcome Scale (GOSE) score at discharge, and mortality.

RESULTS

A total of 1365 head trauma patients 65 years or older were included; 724 were on AT therapy (413 on APs, 151 on ACs, 59 on DOACs, 48 on 2 APs, 38 on AP+AC, and 15 on AP+DOAC) and 641 were not. Among all head trauma patients, the risk of sustaining a TBI was associated with AP use after adjusting for covariates. Of the 731 TBI patients, those using ATs had higher rates of ICH (p <0.0001), functional dependency at discharge (GOSE score ≤ 4; p < 0.0001), and mortality (p < 0.0001). Elevated rates of ICH progression on follow-up CT scanning were observed in patients in the warfarin monotherapy (OR 5.30, p < 0.0001) and warfarin + AP (OR 6.15, p = 0.0011). Risk of mortality was not associated with single antiplatelet use but was notably high with 2 APs (OR 4.66, p = 0.0056), warfarin (OR 5.18, p = 0.0003), and DOAC use (OR 5.09, p = 0.0149).

CONCLUSIONS

Elderly trauma patients on ATs, especially combination therapy, are at elevated risk of ICH and poor outcomes compared with those not on AT therapy. While both AP and warfarin use alone and in combination were associated with significantly elevated odds of sustaining an ICH among TBI patients, only warfarin use was a predictor of hemorrhage progression on follow-up scans. The use of a single AP was not associated with mortality; however, the combination of both aspirin and clopidogrel was. Warfarin and DOAC users had comparable mortality rates; however, DOAC users had lower rates of ICH progression, and fewer survivors were functionally dependent at discharge than were warfarin users. DOACs are an overall safer alternative to warfarin for patients at high risk of falls.

ABBREVIATIONS AC = anticoagulant; AP = antiplatelet; AT = antithrombotic; CCI = Charlson Comorbidity Index; DOAC = direct oral anticoagulant; EDH = epidural hematoma; GCS = Glasgow Coma Scale; GOSE = extended Glasgow Outcome Scale; ICH = intracranial hemorrhage; INR = international normalized ratio; IPH = intraparenchymal hemorrhage; PTT = partial thromboplastin time; SAH = subarachnoid hemorrhage; SDH = subdural hemorrhage; TBI = traumatic brain injury.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Judith Marcoux: Montreal General Hospital, Montreal, QC, Canada. judith.marcoux@mcgill.ca.

INCLUDE WHEN CITING Published online July 5, 2019; DOI: 10.3171/2019.4.JNS19252.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

  • 1

    Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, : Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J 36:32383249, 2015

    • Search Google Scholar
    • Export Citation
  • 2

    Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A: Chronic subdural haematoma in the elderly—a North Wales experience. J R Soc Med 95:290292, 2002

    • Search Google Scholar
    • Export Citation
  • 3

    Balser D, Farooq S, Mehmood T, Reyes M, Samadani U: Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg 123:12091215, 2015

    • Search Google Scholar
    • Export Citation
  • 4

    Bavishi C, Trivedi V, Singh M, Katz E, Messerli FH, Bangalore S: Duration of dual antiplatelet therapy in patients with an acute coronary syndrome undergoing percutaneous coronary intervention. Am J Med 130:1325.e11325.e12, 2017

    • Search Google Scholar
    • Export Citation
  • 5

    Bonville DJ, Ata A, Jahraus CB, Arnold-Lloyd T, Salem L, Rosati C, : Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients. Surgery 150:861868, 2011

    • Search Google Scholar
    • Export Citation
  • 6

    Cull JD, Sakai LM, Sabir I, Johnson B, Tully A, Nagy K, : Outcomes in traumatic brain injury for patients presenting on antiplatelet therapy. Am Surg 81:128132, 2015

    • Search Google Scholar
    • Export Citation
  • 7

    Do MT, Chang VC, Kuran N, Thompson W: Fall-related injuries among Canadian seniors, 2005-2013: an analysis of the Canadian Community Health Survey. Health Promot Chronic Dis Prev Can 35:99108, 2015

    • Search Google Scholar
    • Export Citation
  • 8

    Dossett LA, Riesel JN, Griffin MR, Cotton BA: Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. Arch Surg 146:565570, 2011

    • Search Google Scholar
    • Export Citation
  • 9

    Dunham CM, Hoffman DA, Huang GS, Omert LA, Gemmel DJ, Merrell R: Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study. PLoS One 9:e109473, 2014

    • Search Google Scholar
    • Export Citation
  • 10

    Fabbri A, Servadei F, Marchesini G, Stein SC, Vandelli A: Observational approach to subjects with mild-to-moderate head injury and initial non-neurosurgical lesions. J Neurol Neurosurg Psychiatry 79:11801185, 2008

    • Search Google Scholar
    • Export Citation
  • 11

    Fitzmaurice DA, Blann AD, Lip GYH: Bleeding risks of antithrombotic therapy. BMJ 325:828831, 2002

  • 12

    Fortuna GR, Mueller EW, James LE, Shutter LA, Butler KL: The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. Surgery 144:598605, 2008

    • Search Google Scholar
    • Export Citation
  • 13

    Franko J, Kish KJ, O’Connell BG, Subramanian S, Yuschak JV: Advanced age and preinjury warfarin anticoagulation increase the risk of mortality after head trauma. J Trauma 61:107110, 2006

    • Search Google Scholar
    • Export Citation
  • 14

    Fu TS, Jing R, McFaull SR, Cusimano MD: Recent trends in hospitalization and in-hospital mortality associated with traumatic brain injury in Canada: a nationwide, population-based study. J Trauma Acute Care Surg 79:449454, 2015

    • Search Google Scholar
    • Export Citation
  • 15

    Grandhi R, Harrison G, Voronovich Z, Bauer J, Chen SH, Nicholas D, : Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients. J Trauma Acute Care Surg 78:614621, 2015

    • Search Google Scholar
    • Export Citation
  • 16

    Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF, : Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg 99:666673, 2003

    • Search Google Scholar
    • Export Citation
  • 17

    Inohara T, Xian Y, Liang L, Matsouaka RA, Saver JL, Smith EE, : Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality. JAMA 319:463473, 2018

    • Search Google Scholar
    • Export Citation
  • 18

    Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ: Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma 65:785788, 2008

    • Search Google Scholar
    • Export Citation
  • 19

    Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ: Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma 59:11311139, 2005

    • Search Google Scholar
    • Export Citation
  • 20

    Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, : Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379:215225, 2018

    • Search Google Scholar
    • Export Citation
  • 21

    Julien J, Alsideiri G, Marcoux J, Hasen M, Correa JA, Feyz M, : Antithrombotic agents intake prior to injury does not affect outcome after a traumatic brain injury in hospitalized elderly patients. J Clin Neurosci 38:122125, 2017

    • Search Google Scholar
    • Export Citation
  • 22

    Karni A, Holtzman R, Bass T, Zorman G, Carter L, Rodriguez L, : Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg 67:10981100, 2001

    • Search Google Scholar
    • Export Citation
  • 23

    Kobayashi L, Barmparas G, Bosarge P, Brown CV, Bukur M, Carrick MM, : Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg 82:827835, 2017

    • Search Google Scholar
    • Export Citation
  • 24

    Le Roux P, Pollack CV Jr, Milan M, Schaefer A: Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. J Neurosurg 121 (Suppl):120, 2014

    • Search Google Scholar
    • Export Citation
  • 25

    Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, Allen LaPointe NM, Shah B, : Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review. Ann Intern Med 169:774787, 2018

    • Search Google Scholar
    • Export Citation
  • 26

    Marshall LF, Marshall SB, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, : A new classification of head injury based on computerized tomography. J Neurosurg 75 (Suppl):S14S20, 1991

    • Search Google Scholar
    • Export Citation
  • 27

    Maung AA, Bhattacharya B, Schuster KM, Davis KA: Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg 81:652657, 2016

    • Search Google Scholar
    • Export Citation
  • 28

    Melorose J, Perroy R, Careas S: World population prospects. United Nations 1:587592, 2015

  • 29

    Menon DK, Schwab K, Wright DW, Maas AI: Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil 91:16371640, 2010

    • Search Google Scholar
    • Export Citation
  • 30

    Narum S, Brørs O, Stokland O, Kringen MK: Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre. BMC Emerg Med 16:29, 2016

    • Search Google Scholar
    • Export Citation
  • 31

    Ohm C, Mina A, Howells G, Bair H, Bendick P: Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma 58:518522, 2005

    • Search Google Scholar
    • Export Citation
  • 32

    Pandya U, Malik A, Messina M, Albeiruti AR, Spalding C: Reversal of antiplatelet therapy in traumatic intracranial hemorrhage: Does timing matter? J Clin Neurosci 50:8892, 2018

    • Search Google Scholar
    • Export Citation
  • 33

    Peck KA, Calvo RY, Schechter MS, Sise CB, Kahl JE, Shackford MC, : The impact of preinjury anticoagulants and prescription antiplatelet agents on outcomes in older patients with traumatic brain injury. J Trauma Acute Care Surg 76:431436, 2014

    • Search Google Scholar
    • Export Citation
  • 34

    Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS: Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients. J Trauma 63:525530, 2007

    • Search Google Scholar
    • Export Citation
  • 35

    Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS: Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database. J Trauma 63:519524, 2007

    • Search Google Scholar
    • Export Citation
  • 36

    Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, : Idarucizumab for dabigatran reversal—full cohort analysis. N Engl J Med 377:431441, 2017

    • Search Google Scholar
    • Export Citation
  • 37

    Pozzessere A, Grotts J, Kaminski S: Dabigatran use does not increase intracranial hemorrhage in traumatic geriatric falls when compared with warfarin. Am Surg 81:10391042, 2015

    • Search Google Scholar
    • Export Citation
  • 38

    Rust T, Kiemer N, Erasmus A: Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 13:823827, 2006

    • Search Google Scholar
    • Export Citation
  • 39

    Sandhaug M, Andelic N, Langhammer B, Mygland A: Functional level during the first 2 years after moderate and severe traumatic brain injury. Brain Inj 29:14311438, 2015

    • Search Google Scholar
    • Export Citation
  • 40

    So CH, Eckman MH: Combined aspirin and anticoagulant therapy in patients with atrial fibrillation. J Thromb Thrombolysis 43:717, 2017

    • Search Google Scholar
    • Export Citation
  • 41

    Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, : The Canadian CT Head Rule for patients with minor head injury. Lancet 357:13911396, 2001

    • Search Google Scholar
    • Export Citation
  • 42

    Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:8184, 1974

  • 43

    Tollefsen MH, Vik A, Skandsen T, Sandrød O, Deane SF, Rao V, : Patients with moderate and severe traumatic brain injury: impact of preinjury platelet inhibitor or warfarin treatment. World Neurosurg 114:e209e217, 2018

    • Search Google Scholar
    • Export Citation
  • 44

    Vandiver JW, Diane Beavers K: Combining oral anticoagulation and antiplatelet therapies: appropriate patient selection. J Thromb Thrombolysis 45:423431, 2018

    • Search Google Scholar
    • Export Citation
  • 45

    Wilson JTL, Pettigrew LEL, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573585, 1998

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 76 76 76
Full Text Views 42 42 42
PDF Downloads 27 27 27
EPUB Downloads 0 0 0